'Phase' p14 Searchterm 'Phase' found in 77 articles 4 terms [ • ] - 73 definitions [• ] Result Pages : •
From Siemens Medical Systems;
'The SONOLINE Omnia™ ultrasound system offers mobility, high performance, and ease of use. This digital imaging system delivers excellent 2D, color flow, and Doppler image quality for a variety of general imaging exam types. In addition, the SONOLINE Omnia with cardiac option includes special features that enable use for adult cardiac imaging.'
Device Information and Specification
CLINICAL APPLICATION
Abdomen, small parts, pediatric, prostate, orthopedic, obstetrics, gynecology, cerebrovascular, musculoskeletal, rectal, peripheral vascular (venous and arterial), cardiology
CONFIGURATION
Compact, mobile system
Multi-Frequency and wideband
Wide range of linear/curved/phased array, mechanical, CW pencil probes, laparoscopic, intraoperative, biopsy, TEE transducers
PROBE PORTS
Five
IMAGING OPTIONS
OPTIONAL PACKAGE
Upgradeable applications, cardiac option
IMAGING ENHANCEMENTS
Ultra Fast 3D rendering
STORAGE
Magneto-Optical Drive of 640 MB
DATA PROCESSING
MultiDimensional image processor
•
SonoGen (QW7437) is an anionically charged 2% perfluorocarbon emulsion under development as a transpulmonary myocardial ultrasound contrast agent (UCA). The SonoGen microbubbles have a reduced adherence to the negatively charged vascular endothelium and reduced coalescence. SonoGen, a second generation USCA has the theoretical potential to provide high safety and efficacy and improved tissue grayscale persistence compared to first generation fluorocarbon contrast agents.
Drug Information and Specification
RESEARCH NAME
DEVELOPER
INDICATION -
DEVELOPMENT STAGE Echocardiography - Phase 1
APPLICATION
Intravenous injection
TYPE
Microbubble
Surfactant
CHARGE
Negative
Dodecafluoropentane
MICROBUBBLE SIZE
-
PREPARATION
-
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT! •
From Bracco Diagnostics, Inc.
SonoVue® was first launched in October 2001 and is now available in all European countries. SonoVue is a second generation USCA, designed and optimized with regard to the resistance to pressure. SonoVue is an example of an important family of microbubbles whose membrane consists of phospholipids. SonoVue microbubbles are filled with sulfur hexafluoride (SF6), a gas which has a low solubility and diffuses slowly in blood for the gaseous phase of the microbubbles. In particular, the SonoVue microbubbles, thanks to the high flexibility of their shell, are strongly echogenic in a wide range of frequencies and acoustic pressure and therefore can be used with both destructive and conservative contrast bubble specific imaging methods. See also Coherent Contrast Imaging.
Drug Information and Specification
RESEARCH NAME
BR1
DEVELOPER
INDICATION -
DEVELOPMENT STAGE Contrast enhanced ultrasound -
for sale APPLICATION
Intravenous
TYPE
Microbubble
Lipids: Macrogol 4000, DSPC, DPPG, Palmitic acid
CHARGE
Negative
Sulfurhexafluoride
MICROBUBBLE SIZE
99% < 11μm
PRESENTATION
Presentation 01(with integral Bio-Set transfer system) -25 mg of dry, lyophilized powder in an atmosphere of sulphur hexafluoride in a colorless Type I glass vial, with elastomeric closure and integral transfer system.Type I glass pre-filled syringe containing 5 ml sodium chloride 0.9%w/v solution for injection. - Presentation 02 (with separate MiniSpike transfer system)
STORAGE
No special precautions for storage
PREPARATION
Reconstitute with 5 ml saline
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information
TERRITORY
DISTRIBUTOR
USA, EU
•
Tissue-specific ultrasound contrast agents improve the image contrast resolution through differential uptake. The concentration of microbubble contrast agents within the vasculature, reticulo-endothelial, or lymphatic systems produces an effective passive targeting of these areas. Other contrast media concepts include targeted drug delivery via contrast microbubbles. Tissue-specific ultrasound contrast agents are injected intravenously and taken up by specific tissues or they adhere to specific targets such as venous thrombosis. These effects may require minutes to several hours to reach maximum effectiveness. By enhancing the acoustic differences between normal and diseased tissues, these tissue-specific agents improve the detectability of abnormalities. Some microbubbles accumulate in normal hepatic tissue; some are phagocytosed by Kupffer cells in the reticuloendothelial system and others may stay in the sinusoids. Liver tumors without normal Kupffer cells can be identified by the lack of the typical mosaic color pattern of the induced acoustic emission. The hepatic parenchymal phase, which may last from less than an hour to several days, depending on the specific contrast medium used, may be imaged by bubble-specific modes such as stimulated acoustic emission (color Doppler using high MI) or pulse inversion imaging. Further Reading: News & More:
•
A transducer assembly is the configuration of an ultrasound transducer. Electronic array transducers are composed of multiple crystal elements e.g., linear array and phased array transducer assemblies. A handheld mechanical probe may contain a mechanically driven single element transducer, or a rotating wheel transducer. Static B-scanner (obsolete) had a cylindrical probe with a single disk-shaped piezoelectric crystal. Some probes are designed to be inserted in body cavities (vagina, rectum, esophagus) so that they can get closer to the organ being examined (uterus, prostate gland, heart); getting closer to the region of interest allow for a more detailed view. See also Endocavitary Echography, Endoscopic Ultrasound, Vaginal Transducer and Rectal Probe. Result Pages : |